Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Wolfgang Hiddemann, MD, PhD, discusses acute leukemia research at his institute, LMU Hospital Munich, Munich, Germany. He also discusses the recent approval of the hospital as a CAR T-cell treatment center. This interview took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.